Back

Antithrombotic treatment and valve-related outcomes (GALILEO 4D, ATLANTIS 4D): do they matter .

30 August 2021 (08:00 - 08:11)
Organised by:
Congress Presentation Part of: Antithrombotic therapy after TAVI Interventional Cardiology ESC Premium Access ESC Congress 2021 - The Digital Experience

3 More presentations in this session

Presentation thumbnail
Antithrombotic treatment after TAVI in patients without indication for anticoagulation: anything else than aspirin.
Slides Video
Presentation thumbnail
Antithrombotic treatment after TAVI in patients with indication for anticoagulation.
Slides Video
Presentation thumbnail
Antithrombotic treatment after TAVI in patients with CAD: what matters most valve or atherosclerosis .
Slides Video

Access the full session

Session thumbnail
Antithrombotic therapy after TAVI
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.
28 August 2022
thumbnail
Congress Presentation
Contemporary data evaluating 1-year clinical outcomes in patients with atrial fibrillation and coexisting valvular heart disease: the ETNA-AF-Europe study
25 April 2021
thumbnail
Congress Session
Failing valves and beyond
19 May 2025
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources